List of Excipients in API tobramycin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tobramycin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alcon Laboratories Inc | TOBREX | tobramycin | 0065-0643 | BENZALKONIUM CHLORIDE | |
| Alcon Laboratories Inc | TOBREX | tobramycin | 0065-0643 | BORIC ACID | |
| Alcon Laboratories Inc | TOBREX | tobramycin | 0065-0643 | SODIUM CHLORIDE | |
| Alcon Laboratories Inc | TOBREX | tobramycin | 0065-0643 | SODIUM HYDROXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing tobramycin
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-3750 | SODIUM CHLORIDE |
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-3750 | SODIUM HYDROXIDE |
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-3750 | SULFURIC ACID |
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-3750 | TRISODIUM CITRATE DIHYDRATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for tobramycin
Excipient focus: 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
tobramycin drug variants containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Mylan Specialty LP | tobramycin | 49502-346 |
| Mylan Specialty LP | tobramycin | 49502-401 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0813 |
| >Company | >Ingredient | >NDC |
Excipient focus: BENZALKONIUM CHLORIDE
tobramycin drug variants containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Henry Schein Inc | tobramycin | 0404-7196 |
| Blenheim Pharmacal Inc | tobramycin | 10544-883 |
| MWI | tobramycin | 13985-604 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0813 |
| >Company | >Ingredient | >NDC |
Excipient focus: BORIC ACID
tobramycin drug variants containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Henry Schein Inc | tobramycin | 0404-7196 |
| Blenheim Pharmacal Inc | tobramycin | 10544-883 |
| MWI | tobramycin | 13985-604 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0813 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM CHLORIDE
tobramycin drug variants containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Mylan Specialty LP | tobramycin | 49502-346 |
| Mylan Specialty LP | tobramycin | 49502-401 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0813 |
| >Company | >Ingredient | >NDC |
Excipient focus: CHLOROBUTANOL
tobramycin drug variants containing CHLOROBUTANOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0648 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0813 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0876 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing CHLOROBUTANOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-3750 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
tobramycin drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | tobramycin | 0409-3577 |
| Baxter Healthcare Corporation | tobramycin | 36000-242 |
| Mylan Institutional LLC | tobramycin | 67457-473 |
| Gland Pharma Limited | tobramycin | 68083-241 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
tobramycin drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin / dexamethasone | 0065-0652 |
| Eyevance Pharmaceuticals LLC | tobramycin / dexamethasone | 71776-035 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
tobramycin drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0647 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0953 |
| Padagis US LLC | tobramycin and dexamethasone | 0574-4031 |
| STAT Rx USA LLC | tobramycin and dexamethasone | 16590-223 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
tobramycin drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0813 |
| STAT RX LLC USA | tobramycin | 16590-225 |
| Rebel Distributors Corp | tobramycin | 21695-458 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-3750 |
| >Company | >Ingredient | >NDC |
Excipient focus: NITROGEN
tobramycin drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | tobramycin inhalation solution | 16714-119 |
| Dr Reddy's Laboratories Inc | tobramycin inhalation solution | 43598-605 |
| Sun Pharmaceutical Industries Inc | tobramycin | 47335-171 |
| American Health Packaging | tobramycin | 60687-731 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| >Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
tobramycin drug variants containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0813 |
| STAT RX LLC USA | tobramycin | 16590-225 |
| Rebel Distributors Corp | tobramycin | 21695-458 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-3750 |
| >Company | >Ingredient | >NDC |
Excipient focus: PHENOL
tobramycin drug variants containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | tobramycin | 36000-242 |
| Mylan Institutional LLC | tobramycin | 67457-473 |
| Akorn | tobramycin sulfate | 17478-114 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-306 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
tobramycin drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin / dexamethasone | 0065-0652 |
| Eyevance Pharmaceuticals LLC | tobramycin / dexamethasone | 71776-035 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BISULFITE
tobramycin drug variants containing SODIUM BISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Institutional LLC | tobramycin | 67457-473 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing SODIUM BISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
tobramycin drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-3750 |
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-4085 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0813 |
| Hospira Inc | tobramycin | 0409-3577 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM DITHIONATE
tobramycin drug variants containing SODIUM DITHIONATE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | tobramycin sulfate | 17478-114 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing SODIUM DITHIONATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
tobramycin drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-3750 |
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-4085 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0813 |
| STAT RX LLC USA | tobramycin | 16590-225 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
tobramycin drug variants containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | tobramycin | 0409-3577 |
| Baxter Healthcare Corporation | tobramycin | 36000-242 |
| Gland Pharma Limited | tobramycin | 68083-241 |
| Gland Pharma Limited | tobramycin | 68083-253 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM SULFATE
tobramycin drug variants containing SODIUM SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0647 |
| Alcon Laboratories Inc | tobramycin / dexamethasone | 0065-0652 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0953 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing SODIUM SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0813 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM SULFATE ANHYDROUS
tobramycin drug variants containing SODIUM SULFATE ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Medsource Pharmaceuticals | tobramycin | 45865-119 |
| A-S Medication Solutions | tobramycin | 50090-4190 |
| RPK Pharmaceuticals Inc | tobramycin | 53002-9233 |
| Quality Care Products LLC | tobramycin | 55700-747 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing SODIUM SULFATE ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| >Company | >Ingredient | >NDC |
Excipient focus: SULFURIC ACID
tobramycin drug variants containing SULFURIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0647 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing SULFURIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0813 |
| STAT RX LLC USA | tobramycin | 16590-225 |
| Rebel Distributors Corp | tobramycin | 21695-204 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
tobramycin drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-3750 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| >Company | >Ingredient | >NDC |
Excipient focus: TYLOXAPOL
tobramycin drug variants containing TYLOXAPOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0647 |
| Alcon Laboratories Inc | tobramycin / dexamethasone | 0065-0652 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0953 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing TYLOXAPOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0813 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
tobramycin drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-3750 |
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-4085 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0813 |
| Hospira Inc | tobramycin | 0409-3577 |
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
tobramycin drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin / dexamethasone | 0065-0652 |
| Eyevance Pharmaceuticals LLC | tobramycin / dexamethasone | 71776-035 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Alcon Laboratories Inc | tobramycin | 0065-0644 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0494 |
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
